Radiation and Cancer Biology

SS 05 - Biology 2 - Radiation and Immune Response Session I

49 - Low Dose Radiation Improves Anti-Tumor Responses in a Phase 2 Prospective Trial of Concurrent or Sequential Stereotactic Radiation and Ipilimumab in Patients With Metastatic Lesions

Sunday, October 21
5:25 PM - 5:35 PM
Location: Room 007 C/D

Hampartsoum Barsoumian, PhD

Disclosure:
No relationships to disclose.

Biography:
Hampartsoum Barsoumian, PhD, Postdoctoral Fellow, Department of Radiation Oncology, UT MD Anderson Cancer Center.
My focus is to uncover novel immunotherapeutic interventions in combination with radiation to ultimately achieve optimal response rates and survival in cancer patients. Our pre-clinical and translational cancer research provides a great insight and discoveries for scientific advancements in limiting cancer growth and metastasis.

Presentation(s):

Send Email for Hampartsoum Barsoumian


Assets

49 - Low Dose Radiation Improves Anti-Tumor Responses in a Phase 2 Prospective Trial of Concurrent or Sequential Stereotactic Radiation and Ipilimumab in Patients With Metastatic Lesions



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Low Dose Radiation Improves Anti-Tumor Responses in a Phase 2 Prospective Trial of Concurrent or Sequential Stereotactic Radiation and Ipilimumab in Patients With Metastatic Lesions